Skip to content

Opening book details…

About this Biochemistry, Genetics and Molecular Biology article

Duocarmycin-based antibody–drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress by Yao, Hang-Ping (author);Zhao, Hui (author);Hudson, Rachel (author);Tong, Xiang-Min (author);Wang, Ming-Hai (author) is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Yao, Hang-Ping (author);Zhao, Hui (author);Hudson, Rachel (author);Tong, Xiang-Min (author);Wang, Ming-Hai (author)
Publisher
Elsevier BV
Published
2021
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Yao, Hang-Ping (author);Zhao, Hui (author);Hudson, Rachel (author);Tong, Xiang-Min (author);Wang, Ming-Hai (author)

Browse all works by Yao, Hang-Ping (author);Zhao, Hui (author);Hudson, Rachel (author);Tong, Xiang-Min (author);Wang, Ming-Hai (author)